Health officials say RSV activity can still fluctuate through March.

Market normalization reflects maturation, not decline - strategic transition creates opportunities in precision immunization, ...

Researchers in China recently published a study in Science Translational Medicine describing a new antibody cocktail for ...

Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 at Increased Risk for Severe RSV Over Two RSV Seasons ...

UPMC Children’s Community Pediatrics reports rsv, flu and viral upper respiratory infections this week. Penn Medicine Lancaster General Health Physicians Roseville Pediatrics is reporting a big surge ...

Merck (MRK) reports positive Phase 3 SMART trial results for ENFLONSIA in high-risk infants/children vs RSV, with consistent safety and dosing—read ...

AT 12, Malachi should be hanging out with friends and playing football in the park. But unlike most kids his age, the youngster can’t dress or feed himself and needs round-the-clock ...

After winning an initial U.S. nod in July 2023, Beyfortus has gone on to do gangbusters for Sanofi and AZ, growing total sales 9.5% last year for a total haul of 1.78 billion euros (roughly $2.1 ...

If you have not gotten your flu vaccine, state public health officials are urging you to do so as Illinois could see another surge in cases.

In Roanoke County and surrounding counties, COVID-19 emergency department visit levels remain low. Flu and RSV emergency department rates in Virginia are decreasing as of Feb. 13. Seasonal influenza ...

Merck & Co. MRK on Thursday shared positive second RSV season findings from the Phase 3 SMART trial. The results from the SMART trial were presented at the RSVVW Conference and will be shared with the ...

Kansas has remained in the 'high' category for influenza activity since mid-December.